Brendan Hannah
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-03-16–present
-
Quince Therapeutics, Inc. (QNCX)
Proxy statement
Current -
2023-10-24–2026-07-31
-
Start not stated–2026-09-29
-
Quince Therapeutics, Inc. (QNCX)
Proxy statement
Start not stated–2026-09-29
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Quince Therapeutics, Inc. (QNCX) | Chief Operating Officer, Chief Business Officer and Chief Compliance Officer | $453,750 | $1,263,075 |
| 2024 | Quince Therapeutics, Inc. (QNCX) | Chief Operating Officer, Chief Business Officer and Chief Compliance Officer | $425,000 | $1,365,875 |
| 2023 | Quince Therapeutics, Inc. (QNCX) | Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | $425,000 | $847,500 |
| 2022 | Quince Therapeutics, Inc. (QNCX) | Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | $244,920 | $1,152,926 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.